Home » Topics » Disease categories and therapies » Infection

Infection
RSS

U. of Michigan team discovers non-nucleoside antivirals

Sep. 6, 2000

Orally available carbapenems synthesized and evaluated by Sankyo researchers

Sep. 4, 2000

Immtech awards grant to study potential leishmaniasis treatments

Sep. 4, 2000

Viragen and Zonagen to study topical genital herpes treatment; Zonagen awarded SBIR grant

Sep. 1, 2000

GAR-936 inhibits resistant Gram-positive bacteria

Sep. 1, 2000

Tobramycin shows promise in clinical study of bronchiectasis

Aug. 31, 2000

Pharmacia presents new antiviral agents

Aug. 30, 2000

Carbapenems display potent and broad antianaerobic activity

Aug. 29, 2000

Inhibition of bacterial metabolism offers new tuberculosis drug target

Aug. 25, 2000

Advanced Medicine claims novel antibiotic compounds

Aug. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...